Microbiome engineering: engineered live biotherapeutic products for treating human disease.
Microbiome engineering: engineered live biotherapeutic products for treating human disease.
复制标题
DOI:
10.3389/fbioe.2022.1000873
复制
发表时间:
2022
影响因子:
5.7
通讯作者:
Barnes, Chris P.
中科院分区:
文献类型:
--
作者:
Rutter, Jack W.;Dekker, Linda;Owen, Kimberley A.;Barnes, Chris P.
The human microbiota is implicated in many disease states, including neurological disorders, cancer, and inflammatory diseases. This potentially huge impact on human health has prompted the development of microbiome engineering methods, which attempt to adapt the composition and function of the human host-microbiota system for a therapeutic purpose. One promising method is the use of engineered microorganisms that have been modified to perform a therapeutic function. The majority of these products have only been demonstrated in laboratory models; however, in recent years more concepts have reached the translational stage. This has led to an increase in the number of clinical trials, which are designed to assess the safety and efficacy of these treatments in humans. Within this review, we highlight the progress of some of these microbiome engineering clinical studies, with a focus on engineered live biotherapeutic products.
登录
查看更多内容
影响因子:
9
作者:
Coley, W B
通讯作者:
Coley, W B
影响因子:
--
作者:
Grigoryan, Zoya;Shen, Michael J;Bateman-House, Alison
通讯作者:
Bateman-House, Alison
DOI:
10.1093/synbio/ysac001
发表时间:
2021
期刊:
Synthetic biology (Oxford, England)
影响因子:
--
作者:
Brennan AM
通讯作者:
Brennan AM
影响因子:
28.1
作者:
Cubillos-Ruiz, Andres;Alcantar, Miguel A.;Collins, James J.
通讯作者:
Collins, James J.
影响因子:
4.6
作者:
Crowe JS;Roberts KJ;Carlton TM;Maggiore L;Cubitt MF;Clare S;Harcourt K;Reckless J;MacDonald TT;Ray KP;Vossenkämper A;West MR
通讯作者:
West MR